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Abstract
Large efforts have been taken to search for genes responsible for type 2 diabetes (T2D), but have resulted in only about 20
in humans due to its complexity and heterogeneity. The GK rat, a spontanous T2D model, offers us a superior opportunity to
search for more diabetic genes. Utilizing array comparative genome hybridization (aCGH) technology, we identifed 137 non-
redundant copy number variation (CNV) regions from the GK rats when using normal Wistar rats as control. These CNV
regions (CNVRs) covered approximately 36 Mb nucleotides, accounting for about 1% of the whole genome. By integrating
information from gene annotations and disease knowledge, we investigated the CNVRs comprehensively for mining new
T2D genes. As a result, we prioritized 16 putative protein-coding genes and two microRNA genes (rno-mir-30b and rno-mir-
30d) as good candidates. The catalogue of CNVRs between GK and Wistar rats identified in this work served as a repository
for mining genes that might play roles in the pathogenesis of T2D. Moreover, our efforts in utilizing bioinformatics methods
to prioritize good candidate genes provided a more specific set of putative candidates. These findings would contribute to
the research into the genetic basis of T2D, and thus shed light on its pathogenesis.
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Introduction
Type 2 diabetes (T2D), formally known as non-insulin-
dependent diabetes, accounts for about 90% of the 180 million
diabetic cases around the world [1]. Characterized by defects in
both insulin secretion from pancreatic islet beta-cells and insulin
action in peripheral tissues, this chronic and complex disorder is
supposed to be predisposed by the combined action of multiple
genetic factors [2,3]. In the last two decades, large efforts including
traditional candidate gene mapping and recent high-throughput
genome-wide association studies were performed to unveil the
genetic basis of T2D, and have found nearly 20 human T2D genes
[3–8] and a number of related loci in human, mouse and rat
genomes [9,10]. However, the precise molecular pathogenesis of
this heterogeneous disease remains poorly characterized, and
more T2D-related genes are expected to be uncovered.
The Goto-Kakizaki (GK) rat, a nonobese animal model of T2D,
was developed by repeated inbreeding of glucose-intolerant Wistar
rats [11]. During their development, GK rats suffer from reduced
beta-cell mass and insulin resistance spontaneously, and thus
provide a feasible opportunity to search for susceptible loci,
investigate pathogenesis and develop therapeutic strategies
[12,13]. Several quantitative trait locus (QTL) analyses on this
model have already identified a number of genomic loci harboring
susceptible variants [14–16].
While most disease-association studies of genetic variation
focused on individual nucleotide sequences, large-scale changes
like copy number variations (CNVs), generally defined as the copy
number differences of DNA stretches larger than 1 Kb, have also
been linked to dozens of human diseases [17]. Among the most
well-known cases is the association of Down Syndrome with an
extra copy of chromosome 21 identified by karyotype technology
[18]. New high-throughput approaches like array-based compar-
ative genome hybridization (array CGH, or aCGH) have allowed
the identification of CNVs in the whole genome [19–21], and have
discovered that CNVs are extensively distributed along the
chromosomes. Some of the CNVs are found to be implicated in
complex diseases including neuropsychiatric, autoimmune diseases
and so on [22–25], but the association of CNVs with T2D remains
largely unexploited except that a very recent study confirmed the
implication of a previously identified human gene TSPAN8 [26].
In this work, we conducted a genome-wide screen for CNVs
between GK (T2D model) and Wistar rat (wild type) using array
CGH. A non-redundant set of CNV regions with the total length
of about 36 Mb was identified, including several novel T2D
susceptibility loci involving 16 protein-coding genes (Il18r1,
Cyp4a3, Sult2a1, Sult2a2, Sult2al1, Nos2, Pstpip1, Ugt2b, Uxs1,
RT1-A1, RT1-A3, RT1-Db1, RT1-N1, RT1-N3, RT1-O, and RT1-
S2) and two microRNA genes (rno-mir-30b and rno-mir-30d). It is so
far the first investigation of T2D in GK rats from the viewpoint of
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e14077copy number variation on a genome-wide scale, and the CNVs
identified in GK rats are supposed to shed light on the genetic
basis and pathogenesis of T2D.
Results
Array Data Processing
The comparison between GK and Wistar rats had three
biological replicates (‘‘forward’’) with a dye swap (‘‘reverse’’) for
each, resulting in 6 arrays. The array data were processed
following the procedures described in Materials and Methods. In
the step of quality control, a set of data from a small region on the
sixth chip involving 1278 spots (,0.5%), in addition to 152, 157,
147, 143, 155, and 401 scattered spots of each chip respectively
(,0.08% on average), were filtered out due to poor qualities. To
detect the bias of dye labeling, we hierarchically clustered all 6
chips based on the logarithm ratios (M values). It turned out that
all ‘‘forward’’ chips were distinctly separated from ‘‘reverse’’ ones,
conflicting to the expectation that a dye-swap pair ought to be
grouped together (Figure S1A). Using a linear model, we found
that about 23.7% of the spots showed significant dye bias (p,0.05).
After the correction of dye bias, the new clustering result agreed
with the expectation (Figure S1B). Three dye-swap pairs resulted
in three sets of M values, each of which corresponded to one GK
replicate. The chromosomes were then partitioned according to
the smoothed M values of the probes tiled on them, a process
formally termed as segmentation. The raw intensities and
processed data have been deposited in NCBI’s Gene Expression
Omnibus [27] and are accessible through GEO Series accession
number GSE21387.
CNVR Identification
According to our definition of CNV regions (CNVRs, see
Materials and Methods), we identified about 101 CNVRs in each
GK rat on average, covering approximately 26 M base pairs, i.e.,
about 1% of the rat genome (Table S1 and S2), whose order of
magnitude was the same as the overall length of published rat
CNVRs (22 Mb and 15.5 Mb on two different platforms) [21].
The comparison of the CNVRs identified from the 3 samples
turned out that the majority of them (greater than 70%) were
consistent among individuals (Table S2 and S3). We then merged
the CNVRs from all the 3 samples to a final non-redundant set,
comprising 137 CNVRs, covering 36.31 Mb (Table S4 and the
‘‘Non-redundant’’ column of Table S2). Follow-up investigations
were based on this non-redundant data set.
We plotted the GK/Wistar CNVRs along each chromosome
(Figure 1), and found that they were non-uniformly distributed
with the extreme cases that chromosome 12 and 18 contained
none, while chromosome 7 and 15 contained more CNVRs than
random (4.5 Mb and 2.7 Mb identified vs. only 1.8 Mb and
1.4 Mb expected, respectively). The non-uniform pattern of
CNVRs’ distribution was similar to some extent with the previous
report of rat CNVRs [21].
Investigation into CNVR
In order to mine the genetic variations underpinning the
phenotypic difference between GK and Wistar rats (i.e., diabetic
and non-diabetic), we investigated the CNVRs through examining
their overlapping with various genomic features such as protein-
coding genes and microRNAs. Genomic features covered by the
GK/Wistar CNVRs served as a valuable repository for exploring
genetic factors that play roles in pathogenesis of T2D through
altered copy numbers and thus abnormal expression levels. For a
CNV gene already reported to be T2D-related, our work could
help elucidate its underlying mechanisms, i.e., the gene dosage
effect via copy number variation. More importantly, CNV genes
that were not known to be related to T2D might contain novel
candidates, and it was supposed to be promising to sort out them
from unrelated ones by combining prior biological knowledge
using bioinformatics methods.
Gene and Intergenic Content of CNVRs
Gene and intergenic regions in the GK/Wistar CNVRs were
determined according to the chromosomal locations of rat genes
obtained from NCBI Entrez Gene. Taken together, regions of
3.22 Mb were annotated by Entrez Gene, accounting for only
8.87% of all CNVRs, much less than the proportion of gene
regions in the whole genome (21.35%, Table 1). It seemed that
copy number variation would preferentially reside in intergenic
regions. We further carried out a random simulation to test the
statistical significance (see Materials and Methods), and found that
the overlapping magnitude between randomized intervals and
genes was significantly larger than that between real CNVRs and
genes (7.84 Mb expected in random with a standard deviation of
1.13 Mb vs. 3.22 Mb in fact, p,1e-10), which supported our
inference about the preference of CNVRs to intergenic regions.
This could be partly explained by the purifying selection, which
probably acted on the GK/Wistar CNVs during the process of
selective breeding. Variations in most gene regions might be more
likely to have deleterious effects than those in intergenic regions,
and the stronger negative selection pressure on gene regions might
thus result in the lower observed frequency of CNVs in the gene
regions than in the intergenic regions.
Functional Analysis of CNV Genes
A total of 62 and 72 Entrez genes were identified in ‘‘gain’’ and
‘‘loss’’ CNVRs respectively (Table S4 and S5). We checked
whether these genes contained any of those previously reported to
be related to T2D. A list of 425 known T2D-related genes from
published sources was collected (see Materials and Methods) and
compared with these 134 GK/Wistar CNV genes, but none in
common was found. This result indicated that the potential CNV
factors behind the diabetic pathogenesis of GK rats might be other
genes whose relationships with T2D had not been observed. They
could be genes that had been annotated in NCBI Entrez Gene or
even loci that had never been identified before. In this work, we
focused on mining candidates from known genes (i.e., 134 CNV
genes) according to the aforementioned strategy of adopting prior
knowledge.
We first utilized the knowledgebase of KEGG pathways so as to
identify potential novel candidates that are supposed to be related
to the characteristics of diabetes. After mapping the 134 CNV
genes to KEGG, we found 41 pathways were associated with those
genes (Table S6). The CNV genes falling in the T2D-related
pathways were then selected for further analysis (Table 2). Since
T1D shares some characteristics with T2D, and the involvement
of sulfur metabolism in diabetes has been reported previously
[28,29], the CNV genes (RT1-A1, RT1-A3, RT1-Db1, RT1-N1,
RT1-N3, RT1-O, RT1-S2, Sult2al1, Sult2a1, and Sult2a2)i n
pathways of ‘‘type I diabetes mellitus (04940)’’ and ‘‘sulfur
metabolism (00920)’’ were prioritized. Sugar or fatty acid
metabolisms and PPAR signaling pathways are well known to be
T2D-relevant [2], and thus the CNV genes (Uxs1, Ugt2b, and
Cyp4a3) in pathways of ‘‘starch and sucrose metabolism (00500)’’,
‘‘pentose and glucuronate interconversions (00040)’’, ‘‘fatty acid
metabolism (00071)’’, and ‘‘PPAR signaling (03320)’’ were
preferentially selected as well. We also found that Ugt2b, Cyp4a3,
and sulfur metabolism-related CNV genes (Sult2a1, Sult2a2, and
Putative T2D Loci in CNV
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Niddm44, respectively, strengthening the hypothesis that these
genes may confer susceptibility to T2D.
We noticed that the GK/Wistar CNV genes were significantly
overrepresented in the pathways of olfactory transduction (04740),
immune response (05332, 05330, 05320, and 04612), and cell
adhesion molecule (04514) (Table S6). They were reminiscent of
the functional enrichment results previously reported in CNV
genes of human, mouse and rat, indicating that the bias towards
these functional categories might be a common overall character-
istic of CNV genes [19,21,30].
Since there are complex relationships between diseases,
constituting a ‘‘diseasome’’ [31], diseases directly related to T2D
(‘‘near-T2D’’) could help understand the relatedness of GK/
Wistar CNV genes to T2D. A total of 1097 ‘‘near-T2D’’ genes
were retrieved following the procedure described in Materials and
Methods. Due to the complexity and heterogeneity of diabetes, we
speculated that a part of these genes might also contribute to some
extent to T2D. In fact, five ‘‘near-T2D’’ genes including Pstpip1,
Il18r1, Sult2a1, Nos2, and RT1-Db1, occurred in the GK/Wistar
CNV gene list (Table S7). We checked the relationship between
them and rat QTLs as well, and found that they overlapped QTLs
of ‘‘blood pressure’’, ‘‘serum triglyceride’’, ‘‘serum cholesterol’’, or
‘‘body weight’’. Specifically, Pstpip1, Il18r1, Sult2a1 overlapped the
QTLs of ‘‘Non-insulin dependent diabetes mellitus (Niddm)’’.
There are several web tools for prioritizing human disease
candidate genes from given genomic intervals [32]. The
comparison between our 134 rat CNV genes and the 103 human
T2D genes prioritized by Tiffin et al. [33] found one common
Figure 1. Chromosomal distribution of GK/Wistar CNVRs. Green bars on the left and red bars on the right of chromosomal axes represent CNV
‘‘loss’’ and ‘‘gain’’, respectively. Chromosome ‘‘Un’’ represents the pseudo-chromosome consisting of contigs that can not be confidently mapped to a
specific chromosome.
doi:10.1371/journal.pone.0014077.g001
Table 1. Gene and intergenic constitution in CNVRs and
whole genome.
Status All Gene Region Intergenic Region
CNVR (Mb) Gain 22.75 (100%) 1.91 (8.40%) 20.84 (91.60%)
Loss 13.56 (100%) 1.31 (9.66%) 12.25 (90.34%)
Total 36.31 (100%) 3.22 (8.87%) 33.09 (91.13%)
Genome (Gb) 2.83 (100%) 0.60 (21.35%) 2.23 (78.65%)
doi:10.1371/journal.pone.0014077.t001
Table 2. Selected GK/Wistar CNV genes involved in
diabetes-related pathways.
KEGG pathway (ID) Status CNV Gene
Type I diabetes mellitus (04940) Gain RT1-A1, RT1-A3, RT1-Db1
Loss RT1-N1, RT1-N3,
RT1-O, RT1-S2
Sulfur metabolism (00920) Gain Sult2al1, Sult2a1, Sult2a2
Starch and sucrose metabolism (00500) Gain Uxs1
Loss Ugt2b
Pentose and glucuronate
interconversions (00040)
Loss Ugt2b
Fatty acid metabolism (00071) Loss Cyp4a3
PPAR signaling pathway (03320) Loss Cyp4a3
doi:10.1371/journal.pone.0014077.t002
Putative T2D Loci in CNV
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pathway mapping.
Taken together, the above analysis highlighted 16 GK/Wistar
CNV genes, providing a valuable collection of most likely disease
candidates to be prioritized for further experiments (Table S8).
These genes are unequally distributed on several different
chromosomes and different CNV regions. Among them, all the
7 RT1 genes are clustered in two regions of chromosome 20, i.e.,
RT1-A1, RT1-A3, and RT1-Db1 in one cluster (the gap between
cnv.gain.54 and cnv.gain.53 is only ,345 Kb according to Table
S4) while RT1-N1, RT1-N3, RT1-O, and RT1-S2 in the other one.
However, the 3 genes in the first cluster are only supported by one
sample, which reduced our confidence that these genes are likely
to contribute to susceptibility to T2D. The three Sult2a genes are
clustered in a gain region on chromosome 1, and are supported by
all three samples. The other six genes are distributed on six
different chromosomes respectively, with Uxs1, Cyp4a3, and Nos2
identified in all three samples. These data will offer additional
clues for the follow-up prioritization of these 16 genes.
Ultraconserved Elements and MicroRNAs
According to the aforementioned analysis, more than 90% of
the CNVRs were intergenic regions. Although the intergenic
regions, as well as non-coding gene regions such as introns and
UTRs, may not involve as many functional features as coding
regions, recent studies demonstrated that some of non-coding
regions can play important regulatory roles. We therefore
extended our focus beyond coding regions to include ultracon-
served elements and microRNAs.
Ultraconserved elements are defined as stretches of DNA
(longer than 200 bp) which are extremely conserved in ortholo-
gous regions of the human, rat and mouse genomes. It has been
speculated that they are under strong purifying selection, and may
play important roles in DNA binding, RNA processing and
transcriptional regulation [34]. We compared the GK/Wistar
CNVRs and 481 published ultraconserved elements (126.7 Kb in
total mapped to rat genome assembly rn4), but no overlap was
found, while ,1.5 Kb would be expected by chance (p=0.027),
consistent with the conclusions reported in other studies [21,35].
These results in combination with the above gene and intergenic
content of CNVRs, supported the opinion that, as a global trend,
most GK/Wistar CNVs were found in non-functional rather than
functional regions, probably due to the purifying selection during
the selective breeding.
Considering the significant contributions of microRNAs to
development processes and the pathogenesis of diseases at the
post-transcriptional level [36–37], we examined if there were any
microRNA genes in our GK/Wistar CNVRs. By comparing the
genomic positions of known rat microRNA genes with those of
GK/Wistar CNVRs, we found that rno-mir-30b and rno-mir-30d
were simultaneously covered by a ‘‘gain’’ region on chromosome 7
in all three samples (Table S9) within a region of only 3.8 Kb.
Interestingly, several T2D QTLs and various relevant QTLs
including body weight, blood pressure, and serum triglyceride level
QTLs were also located in this region, implying that copy number
variation of these microRNA genes could be correlated to these
quantitative traits (Figure 2). A recent publication reported that
altered expression of mir-30d, as a response to glucose, influences
insulin gene expression in mouse Min6, a pancreatic island cell
line [38]. Although further investigations are still needed, we
obtained additional evidence supporting the involvement of mir-
30b/30d in T2D pathogenesis by means of copy number variation.
To further elucidate the putative roles of mir-30b/30d,w e
looked at their predicted targets using MicroCosm [39]. Taken
together, there were 1868 and 1776 targets for rno-mir-30b and rno-
mir-30d, respectively. Like the analysis performed on CNV genes,
we compared these target genes with the 425 T2D-related genes.
It turned out that 39 and 35 targets of mir-30b and mir-30d
occurred in this T2D gene list respectively, and were both
significantly overrepresented (p=0.000273 and 0.00152, detailed
targets listed in Table 3), supporting the hypothesis of mir-30b and
mir-30d’s involvement in T2D. Among them, Pparg and Akt2
(targets of mir-30b), Hnf1b, Hnf4a, and Lmna (targets of mir-30d), are
well-known genes implicated in T2D or insulin resistance. We
then mapped these microRNA targets to KEGG pathways, and
found that 5(2), 12(6), 10(4), 14(12), 4(5) and 1(3) targets of mir-
30b(mir-30d) belonged to the pathways of ‘‘type II diabetes
(04930)’’, ‘‘Type I diabetes (04940)’’, ‘‘pancreatic cancer
(05212)’’, ‘‘insulin signaling (04910)’’, ‘‘PPAR signaling (03320)’’
and ‘‘maturity onset diabetes of the young (04950)’’, respectively
(Table 4). Moreover, several fatty acid or sugar-related metabolism
pathways (00010, 00030, 00512, 00051, 00071, and 01030) were
enriched with these predicted targets with considerably low p
values (Table S10 and Table S11). These results provided extra
evidence of a role for mir-30b/30d in diabetes pathogenesis.
Discussion
In this study, we identified a catalogue of CNVRs between GK
and Wistar rats using tiling array CGH. Given the hypothesis that
the phenotypic difference between GK and Wistar (diabetic and
non-diabetic) ought to be attributed in a large part to their
genomic variations, we carried out a series of bioinformatics
functional analysis on these GK/Wistar CNVRs to narrow down
the scope for further exploration of T2D candidate genes. A total
of 16 protein-coding genes and 2 microRNA genes were
prioritized for further analysis (Table S8 and Table 3), which
might in combination or alone contribute to the pathogenesis of
diabetes on the basis of varied copy number in the genomic level.
We believe that the list of GK/Wistar CNVRs is a valuable
repository for mining genetic factors that play roles in pathogenesis
of T2D through altered copy numbers. In the bioinformatics
analysis, we focused on the Entrez protein-coding genes and
microRNAs with known genomic locations, and found 134
protein-coding genes and 2 microRNAs implicated in GK/Wistar
CNVRs. By integrating available knowledge about T2D, we
prioritized 16 protein-coding genes and 2 microRNAs as good
candidates for further experiments for validating their contribution
to the pathogenesis of T2D by means of dosage effect. In addition,
CNVRs without annotations of Entrez genes or microRNAs may
also be worth further investigation. We checked other gene
annotations from UCSC ‘‘KnownGene’’, ‘‘RefGene’’, ‘‘mRNA’’,
‘‘EST’’, and ‘‘EnsemblGene’’, and found various coding signals
outside the scope of Entrez gene annotations (Table S12). They
could be novel genes, but additional evidence is needed.
Among the preferentially selected protein-coding genes, Il18r1
was previously identified as a T2D candidate gene in a cohort of
African American families [40]. The gene Cyp4a3 is involved in
fatty acid metabolism and Pparg signaling, disorders of which are
closely related to the pathogenesis of T2D [2,41]. As mentioned in
the results, several sulfur-containing compounds are used in the
therapy of diabetes while the therapeutic mechanism is not yet
clear. Thus the identification of sult2a1, sult2a2 and sult2al1 echoes
the beneficial effects of sulfur-containing compounds, and further
study might provide insights into the mechanism.
We analyzed a public dataset GSE13271 [42], currently the
only GK/Wistar differential expression dataset in NCBI GEO,
and identified 30 sets of differentially expressed genes (DEGs)
Putative T2D Loci in CNV
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time points, and feeding conditions. When comparing these DEGs
with the GK/Wistar CNV genes identified in this work, we found
that some of them showed consistency in certain tissues (Table
S13), including RT1-N1 in muscle, Ugt2b in liver, RT1-A3 in all
three tissues (liver, fat, and muscle). There was also inconsistency
between CNV and differential expression, including Sult2al1,
Sult2a1, Sult2a2, Uxs1, RT1-Db1, Cyp4a3, Pstpip1, and Il18r1 in
certain conditions. Generally speaking, it is reasonably supposed
that the consistent genes may be more likely involved in T2D, but
we cannot exclude the possibilities of other genes also being
involved.
There have been multiple reports concerning the implications of
microRNAs in diabetes, but almost all of them focused on the
expression profiling, which are mainly related to the intermediate
process of disease development [38,43–46]. Here, for the first time
we found evidence that microRNAs might be related to T2D by
means of copy number variation. We proposed that the altered
copy number of mir-30b and mir-30d in GK rats could contribute
to the pathogenesis of T2D. It might occur at the stage of disease
initiation: compared with normal Wistar rat, varied copy number
of mir-30b and mir-30d in GK might result in altered expression
level at some specific developmental stages and at some specific
tissues, and the altered expression of mir-30b and mir-30d might
then lead to dysfunction of some specific targets, contributing to
the development of T2D. All these predisposing factors might act
in combination as they are involved in this complex disease. In
addition to the aforementioned study of the expression of mir-30d,
there were several other expression profiling reports suggesting the
involvement of mir-30 family in diabetes or adipogenesis [47–49].
We re-analyzed a public microRNA expression dataset
GSE13920, currently the only one microRNA profiling in GK
Figure 2. The microRNA rno-mir-30b and rno-mir-30d located in T2D QTLs. The QTLs of Niddm (Non-insulin dependent diabetes mellitus) 14
and 19 cover these 2 microRNAs. In addition, there are many other QTLs like ‘‘serum triglyceride 14’’, ‘‘serum cholesterol 3’’, ‘‘blood pressure 181/215/
216/265/266’’, ‘‘body weight 9/12/17’’ in this region, and these traits are known to be related to diabetes. This figure was prepared using UCSC
genome browser.
doi:10.1371/journal.pone.0014077.g002
Table 3. Targets of rno-mir-30b and rno-mir-30d in T2D-related genes.
microRNA Predicted targets
rno-mir-30b Aire, Akt2
*, Bud13, Cblb, Cdc123, Eif4e, Elf1, Fgb, Gcg, Hdac3, Irf4, Kcnj5, Klrg1, Mapk8, Med14, Mgea5, Mttp, Neurod1, Nfkb1, Nmu, Parl, Pbx1, Pfkl,
Pik3r2, Pparg
*, Ppargc1b, Prkce, Prmt2, Rapgef4, Rpa2, Rrad, Serpine1, Slc2a10, Socs1, Srebf1, Tlr4, Ubl5, Ucp2, Wdr42a
rno-mir-30d Ace, Cblb, Cdh15, Cp, Cyb5r4, Egfr, Foxo1, Hdac3, Hnf1b
*, Hnf4a
*, Inpp5k, Irf4, Lgr5, Lmna
*, Neurod1, Nfkb2, Nfkbia, Nr1i3, Nr4a1, Parl, Pbx1,
Pik3r2, Ppargc1b, Ppp1r3d, Prkar2b, Ptf1a, Rbp4, Rrad, Sell, Sirt1, Slc2a10, Socs1, Sorcs1, Srebf1, Tlr4
*Well-known genes implicated in T2D or insulin resistance.
doi:10.1371/journal.pone.0014077.t003
Putative T2D Loci in CNV
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30b/30d in muscle cells were strikingly different between normal
rat and T2D rat (Figure S2). The expression change was, however,
contradictory to the direction of copy number variation detected
here. We noticed that there was a protein-coding gene named Zfat
which is located at the same gain CNVR as mir-30b and mir-30d
are positioned in. By inspecting the dataset of GSE13271, we
found that Zfat was up-regulated in liver, but down-regulated in
adipose tissues and muscles (Table S13). The down-regulation of
Zfat in muscles is consistent with that of mir-30b and mir-30d, that
is, all of them are inconsistent with the CNV gain, suggesting
further investigations are still needed to confirm these results and
to unveil detailed mechanisms.
Although we aimed to find diabetes-specific variants, we noticed
that the GK/Wistar CNVRs identified in this work shared quite a
few global characteristics with previously reported CNV investi-
gations [19,21,30]. For example, our CNVRs from one GK
sample accounted for about 1% of the whole genome, non-
randomly distributed on the chromosomes, and enriched with
genes concerning olfactory transduction and immune response
(Table S6), suggesting possible common factors involved in the
genesis or maintenance of CNVs. The preference of the GK/
Wistar CNVRs for intergenic regions was in accordance with
several published reports [19,50], while some others declared the
opposite [21,51]. It might be due to the distinctiveness of different
study subjects or other reasons not revealed currently.
We attempted to explore the causes of T2D of GK rats from
CNV data in this study. Admittedly, there were still several aspects
not covered here. T2D is a heterogeneous disease, and it may be
caused by multiple factors including genetic variations (point
variations, structural variations like inversion, translocation, small
indels and CNVs) and environmental effects. It is also reported
that epigenetic factors may be implicated in the T2D of GK rats
[12]. In the present work, only CNVs are concerned, and future
studies concerning all these points and validation of the candidates
are thus highly anticipated. Array probe design with higher
density, hybridizations with more GK individuals, and rat genome
annotation with better accuracy will improve the quality of the
CNVR data and subsequent analyses. It will be even more
promising if next-generation sequencing technology is adopted for
CNV discovery, since it can not only define the CNV boundaries
more accurately, but also detect inversions or translocations that
cannot otherwise be detected by array CGH. In addition,
sequencing can identify novel sequence stretches that are not
presented in the current reference genome assembly, paving a
broader way to identifying T2D and other disease genes.
Materials and Methods
Sample Preparation, Array Hybridization and Data
Extraction
Three male Goto-Kakizaki rats and 8 male Wistar rats were
obtained from SLAC Co., Ltd (Shanghai, China). The rats were
anesthetized by formalin at the age of 8 weeks, and the blood was
taken from the pericardia and anticoagulated. Genomic DNA was
then isolated using DNeasy Blood & Tissue Kit (Qiagen, p/n
69504). All animal experiments were approved by the Biomedical
Research Ethics Committee of Shanghai Institutes for Biological
Table 4. The targets of rno-mir-30b and rno-mir-30d involved in diabetes-related pathways.
KEGG pathway microRNA Targets
* Glycolysis/Gluconeogenesis rno-mir-30b Aldoc, Gapdh, Ldhb, Pgm1, Aldh3a1, Pfkl, Aldh1a3, LOC291543, Gpi, LOC294844, Aldh2,
RGD1561178, Adh4, Aldh1a7, LOC303448, RGD1563446, LOC366864, RGD1566272, RGD1564688,
RGD1565928, RGD1562758, RGD1559704, LOC499896, LOC500912, RGD1565368, LOC680538,
LOC682005, LOC685186, LOC688677, Gapdh-ps2
rno-mir-30d Fbp2, Adh7, Adh1, Ldhb, Pgk1, Pgm1, Aldh3a1, LOC291543, RGD1561881, Aldh2, Adh4, RGD1565238
* Pentose phosphate pathway rno-mir-30b Aldoc, Pgm1, Pfkl, Gpi, Tkt
O-Glycan biosynthesis rno-mir-30b Ogt, Galnt13, Galnt3, Galnt1
rno-mir-30d Ogt, Galnt13, Galnt3, C1galt1
Fructose and mannose metabolism rno-mir-30b Aldoc, Pfkfb1, Pfkl, Mpi, Fpgt
Fatty acid metabolism rno-mir-30d Adh7, Adh1, Cpt2, Aldh2, Adh4, Dci, Acox3
Glycan structures - biosynthesis 1 rno-mir-30d Ogt, Man1a1, Chst1, Ext1, B4galt4, Galnt13, Ddost, Galnt3, C1galt1, Mgat5, Hs3st1, Chst3, Mgat2
Insulin signaling pathway rno-mir-30b Braf, Mapk8, Eif4e, Cblb, Pygm, Akt2, Socs1, Pfkl, Pik3r2, Calml3, Cep152, Rps6kb2, Srebf1, Pik3cb
rno-mir-30d Fbp2, Cblb, Calm1, Calm3, Prkar2b, Pygm, Socs1, Pik3r2, Phkb, Calm2, Srebf1, Foxo1
PPAR signaling pathway rno-mir-30b Pparg, Slc27a6, Gk, Cyp8b1
rno-mir-30d Cpt2, Slc27a6, Gk, Fabp4, Acox3
Type II diabetes mellitus rno-mir-30b Mapk8, Socs1, Prkce, Pik3r2, Pik3cb
rno-mir-30d Socs1, Pik3r2
Pancreatic cancer rno-mir-30b Braf, Mapk8, Erbb2, Akt2, Pik3r2, Brca2, Rac2, Rad51, Nfkb1, Pik3cb
rno-mir-30d Egfr, Pik3r2, Brca2, Rad51
Maturity onset diabetes of the young (MODY) rno-mir-30b Neurod1
rno-mir-30d Hnf1b, Hnf4a, Neurod1
Type I diabetes mellitus rno-mir-30b RT1-A1, RT1-A2, RT1-Cl, RT1-CE12, RT1-CE1, RT1-A3, RT1-M6-2, RT1-CE14, RT1-CE4, RT1-M6-1, RT1-
CE16, Ica1
rno-mir-30d Gzmb, Il1a, Ifng, RT1-Db1, H2-Ob, Cd86
*Significantly or nearly significantly enriched, p,0.10.
doi:10.1371/journal.pone.0014077.t004
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from 3 individuals of GK rat was used as test sample separately,
while DNA pooled from 8 Wistar rats served as a common
reference.
We used rat genome CGH 244A (Agilent, p/n G4435A) as our
oligo aCGH platform, which comprises about 240 K 60-mer
probes tiled over the rat genome with the median probe spacing of
7.9 Kb (4.7 Kb in gene regions). Labeling of genomic DNA and
hybridization to tiling arrays were performed according to
standard Agilent protocols. In brief, 2 mg of genomic DNA from
test sample (GK) and 2 mg from reference (Wistar) were digested
by AluI/RsaI and labeled by random primer, incorporating Cy5
(red) and Cy3 (green) fluorescent dyes. Test and reference were co-
hybridized to the Agilent 244A microarray in the hybridization
chamber (Agilent, p/n G2545A) at 65 degrees Centigrade and
20 rpm for 40 hours. For each sample, a dye-swap labeling and
hybridization was carried out. In a ‘‘forward’’ hybridization, test
and reference samples were dyed with Cy5 and Cy3 respectively,
while in the corresponding ‘‘reverse’’ hybridization, test and
reference were dyed with Cy3 and Cy5 respectively.
Following hybridization and wash, arrays were imaged using the
US80803205 high-resolution scanner (Agilent, p/n G2505B).
Fluorescence intensities were extracted using Agilent’s Feature
Extraction software and used for follow-up processing procedures.
Data Processing
The data were processed in the R programming environment
(2.9.0), and the snapCGH (1.12.0), limma (1.18.0), MANOR
(1.16.0) and DNAcopy (1.18.0) packages from bioconductor
project (http://www.bioconductor.org/), and several in-house
scripts were adopted for quality control, normalization and
segmentation. The data processing framework was mainly based
on snapCGH [52], and some necessary modifications were made
to fit the requirements of quality control and the dye-swap design.
The whole pipeline involving data processing and CNVR
identification is illustrated in Figure 3. The signal intensities from
the two channels (Cy5 and Cy3) were transformed to the form of
logarithm ratios (M values), and were then input to MANOR for
quality assessment, especially for adjusting potential global
gradient and detecting chip regions with low quality [53]. After
that, all M values were normalized with the ‘‘loess’’ coefficients
calculated from the M values between 21 and 1 (‘‘weighted loess’’)
[54], and those from ‘‘reverse’’ hybridizations were multiplied by
21 to make them comparable with those from ‘‘forward’’ ones
(i.e., M values of Wistar vs GK converted to M values of GK vs
Wistar).
We further developed a linear model using limma to correct the
spot-specific dye bias [55]. For each feature spot, we had 6 M
values corresponding to 6 arrays. In our model, each measured M
value was written as:
Mi~a:GkWisizb:Dyeizei
where i took values from 1 to 6, representing different arrays. The
item of a was used to model the contribution of genomic
difference between GK and Wistar rats, while the item of b was
for dye bias. The item of e represented the contribution of other
factors including difference between GK individuals and random
errors. In all hybridizations (i=1, …, 6), GkWis took the value of
1. The Dye took the value of 1 for ‘‘forward’’ hybridizations (i=1,
2, 3) and 21 for ‘‘reverse’’ ones (i=4, 5, 6), indicating the
different direction of dye bias in ‘‘forward’’ and ‘‘reverse’’
hybridizations. The dye bias correction was to subtract the
component of b?Dyei from M values. By minimizing the sum of
square of e, we were able to obtain the estimates of a and b in
limma. The dendrograms used to illustrate the necessity of spot-
specific dye bias correction were generated by hierarchical
clustering with Ward’s minimum variance method using Euclid-
ean distances.
After correction of the dye bias, 6 arrays were merged into 3
independent datasets corresponding to 3 GK samples. M values
from probe replicates were also averaged. And then segmentation
was carried out using DNAcopy package, which aims to fragment
the chromosomes into intervals according to the smoothed M
values of probes tiled alongside the genome, i.e., the copy number
status of the corresponding genome regions [56].
CNVR Identification
In this work, a CNV region (CNVR) was defined based on the
smoothed M values: three or more consecutive probes whose M
values were all greater than 0.5 (‘‘gain’’) or all less than 20.5
(‘‘loss’’) delineated a core region, which extended additional 5 Kb
at both sides to define a CNVR. When comparing two diploids,
the M value of 0.5 suggests that one of the two alleles is duplicated
(log2(3/2)<0.58). That was why 0.5 was set as the M cutoff. The
extension of CNVRs for 5 Kb at both sides was due to that 5 Kb is
similar to half of the median spacing between consecutive probes
on Agilent 244A platform, approximately representing the
coverage of a probe at one single side.
When merging CNVRs of multiple samples to a non-redundant
set, the criterion was that the region which was detected by at
least 1 sample was supposed to be kept in the final set, and
overlapped regions be merged, similar to ‘‘union’’ in set
operations. Although ‘‘union’’ of 3 samples inevitably resulted in
higher false positive rate of CNVR identification, we still preferred
high coverage to high precision. The genomic coordinates of
CNVRs were referred to the UCSC rn4 assembly (based on
RGSC 3.4), and their chromosomal distribution was plotted using
Caryoscope [57].
Figure 3. The pipeline of microarray data processing. The shapes
bordered by dash-line represent the steps specifically implemented for
this study.
doi:10.1371/journal.pone.0014077.g003
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The analyses were also conducted in the R programming
environment. The chromosomal locations of NCBI Entrez genes
were obtained from the package org.Rn.eg.db (2.2.11) in
Bioconductor. Coordinates of genomic features adopted in this
work were all referred to the UCSC rn4 assembly, in consistence
with those of CNVRs. The CNV genes were identified through
genomic interval overlapping, i.e., if one overlapped any of the
GK/Wistar CNVRs, it was counted in. In the calculation of the
length of gene regions in the CNVRs or in the whole genome,
overlapping gene regions were merged to non-redundant intervals
to avoid duplicated counting.
The random simulation for estimating the statistical significance
of CNVRs’ preference to intergenic regions was designed as
follows. The same counts of genomic intervals as CNVRs (137 in
this study) were randomly chosen from the rat chromosomes, and
their lengths were also the same as the corresponding CNVRs.
The summed length of the overlaps between them and Entrez
gene regions was then calculated as the statistic. After 1000 rounds
of this process, an empirical distribution representing the overlap
magnitudes between gene regions and random genomic intervals
was obtained. And thus the probability of the overlap length less
than that between real CNVRs and gene regions (3.22 Mb in this
study) could be estimated.
The T2D-related gene list was compiled from an article which
collected 172 human T2D-related genes [10] and the T2D-DB
database [9] which contained 330, 60, and 36 genes from human,
mouse and rat, respectively. Using NCBI HomoloGene Release 64
(http://www.ncbi.nlm.nih.gov/homologene), we obtained the
corresponding rat homologues of human and mouse genes. A
total of 425 non-redundant rat genes turned out to form the T2D-
related gene list.
In addition to org.Rn.eg.db (2.2.11), the bioconductor packages
including KEGG.db (2.2.11), and GOstats (2.10.0) were used to
obtain the gene to pathway mappings, and to test the significance
of pathway enrichments. The ‘‘near-T2D’’ gene set was prepared
from a study on human ‘‘diseasome’’ [31], where all the diseases
were organized in a inter-connected network. We collected all the
diseases that directly connected to T2D in this network, and then
all the genes corresponding to these diseases were retrieved as the
‘‘near-T2D’’ gene set. The rat homologues of ‘‘near-T2D’’ human
genes were also obtained from the NCBI HomoloGene release 64,
resulting in 1097 rat ‘‘near-T2D’’ genes. The rat QTL data were
from the source of RGD [58], and their overlap with CNV genes
were checked through navigating the UCSC genome browser
manually [59]. Tiffin’s human T2D gene set [33] were originally
represented by Ensembl gene IDs and were converted to Entrez
gene IDs using org.Hs.eg.db (2.2.11). The human homologues of
the rat CNV genes were obtained using HomoloGene release 64
as well, which made feasible the comparison between CNV genes
and Tiffin’s dataset.
The locations of ultraconserved elements on rat genome
(assembly rn4) were determined using BLAT [60]. The 481
published elements resulted in 484 positions due to non-unique
mapping. The simulation for estimating the significance of the
overlap between CNVRs and the ultraconserved elements was
conducted following the previous procedure for overlap between
CNVRs and gene regions.
Rat microRNAs along with their genomic coordinates based on
assembly rn4 were downloaded from miRBase (http://www.
mirbase.org/, release 14) [61]. Predicted targets of mature
microRNAs were obtained from MicroCosm (http://www.ebi.
ac.uk/enright-srv/microcosm/htdocs/targets/v5/) based on the
miRanda algorithm [39]. Since rno-mir-30b was processed to two
mature forms, rno-miR-30b-3p and rno-miR-30b-5p, their targets
were combined for further analysis; and it was the same with rno-
mir-30d, where the targets of rno-miR-30d and rno-miR-30d* were
merged. The targets in MicroCosm presented as Ensembl
transcript IDs were converted to Entrez gene IDs utilizing the
mappings provided by the package org.Rn.eg.db. The significance
of the targets’ enrichment in the 425 T2D-related genes was
calculated in a hypergeometric distribution by taking all the genes
in the package ‘‘org.Rn.eg.db’’ as background. The pathway
mapping and enrichment analysis of targets were performed as the
same as those of CNV genes using the package of GOstats.
The super series GSE13271 contains three expression datasets:
GSE13268 (adipose), GSE13269 (muscle), and GSE13270 (liver),
all of which profiled the gene expressions of GK and Wistar rats in
normal and high fat diet, and in 5 time points, thus resulting in 30
conditions. For genes with more than one probeset, we kept the
one which was most often associated with the highest expression
level. If there were still more than one probeset left, the intensities
of the remaining probesets were averaged to represent the
expression level of this gene. We then performed t-test to identify
differentially expressed genes between GK and Wistar samples,
and calculated the base 2 logarithm of the fold changes for the
expression levels. FDR correction using BH method [62] was
adopted to adjust the raw p-values of multiple hypothesis testings,
and 0.2 was chosen as the threshold, which means that more than
80% of the identified genes are truly differentially expressed. As for
the microRNA expression dataset GSE13920, we simply looked at
the mean signal intensities after removing mean background noise
for each probe of mir-30b and mir-30d.
Supporting Information
Figure S1 Effect of dye bias correction. The samples were
clustered according to the corresponding M values, before (A) and
after (B) correcting the systematic errors caused by dye bias,
respectively. GK19, GK29 and GK49 represent the corresponding
‘‘reverse’’ hybridizations for GK1, GK2, and GK4, respectively.
Found at: doi:10.1371/journal.pone.0014077.s001 (0.08 MB TIF)
Figure S2 Expression levels of mir-30b/30d in the muscle of
GK and Wistar Rat. Data were downloaded from GEO
(GSE13920), and two GK samples and 2 Wistar samples were
hybridized on 4 single-channel microarrays respectively. The
expression level was represented by the mean foreground signal
intensity after subtracting the mean background signal intensity.
Each probe duplicated 3 times.
Found at: doi:10.1371/journal.pone.0014077.s002 (0.22 MB TIF)
Table S1 CNVRs identified in 3 GK rat DNA samples.
Found at: doi:10.1371/journal.pone.0014077.s003 (0.05 MB
XLS)
Table S2 Simple statistics of GK/Wistar CNVRs in 3 samples.
Found at: doi:10.1371/journal.pone.0014077.s004 (0.04 MB
DOC)
Table S3 Common CNVRs between samples (Mb).
Found at: doi:10.1371/journal.pone.0014077.s005 (0.03 MB
DOC)
Table S4 Non-redundant CNVRs and Entrez genes directly
overlapped them.
Found at: doi:10.1371/journal.pone.0014077.s006 (0.06 MB
XLS)
Table S5 Genes identified from GK/Wistar CNVRs.
Found at: doi:10.1371/journal.pone.0014077.s007 (0.03 MB
XLS)
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XLS)
Table S7 CNV genes occurred in ‘‘near-T2D’’ diseases.
Found at: doi:10.1371/journal.pone.0014077.s009 (0.02 MB
XLS)
Table S8 Preferentially selected protein-coding genes in GK/
Wistar CNVRs.
Found at: doi:10.1371/journal.pone.0014077.s010 (0.02 MB
XLS)
Table S9 Logarithm (base 2) ratios of CNVRs (GK vs. Wistar)
containing microRNAs.
Found at: doi:10.1371/journal.pone.0014077.s011 (0.01 MB
XLS)
Table S10 Pathway mapping and enrichment of the targets of
rno-mir-30b.
Found at: doi:10.1371/journal.pone.0014077.s012 (0.04 MB
XLS)
Table S11 Pathway mapping and enrichment of the targets of
rno-mir-30d.
Found at: doi:10.1371/journal.pone.0014077.s013 (0.04 MB
XLS)
Table S12 Coding signals annotated in sources other than
Entrez Gene (EG).
Found at: doi:10.1371/journal.pone.0014077.s014 (0.03 MB
DOC)
Table S13 Comparison of CNV genes and differentially
expressed genes.
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